Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) insider Isaiah Fields sold 2,000 shares of the firm's stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the transaction, the insider directly owned 55,588 shares of the company's stock, valued at $29,740,135.88. The trade was a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Axon Enterprise Stock Up 1.2%
AXON opened at $579.09 on Wednesday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53. The company has a market cap of $46.56 billion, a price-to-earnings ratio of 380.98, a PEG ratio of 12.21 and a beta of 1.46. Axon Enterprise, Inc has a one year low of $396.41 and a one year high of $885.91. The business's fifty day moving average is $537.12 and its two-hundred day moving average is $621.06.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business had revenue of $796.72 million during the quarter, compared to the consensus estimate of $755.29 million. During the same quarter in the previous year, the company posted $2.08 EPS. The business's revenue was up 38.5% on a year-over-year basis. Analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.
Institutional Investors Weigh In On Axon Enterprise
Several hedge funds have recently made changes to their positions in the business. Creative Financial Designs Inc. ADV purchased a new position in Axon Enterprise during the fourth quarter worth about $28,000. Stone House Investment Management LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter valued at about $29,000. New Millennium Group LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter worth about $29,000. Sound Income Strategies LLC boosted its position in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company's stock worth $30,000 after acquiring an additional 44 shares during the last quarter. Finally, Camelot Portfolios LLC purchased a new stake in Axon Enterprise in the fourth quarter valued at approximately $30,000. Institutional investors and hedge funds own 79.08% of the company's stock.
Key Stories Impacting Axon Enterprise
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: TD Cowen and other analysts boosted Axon’s outlook after strong bookings and continued growth in subscription/ARR, leading to an upward revision in price targets that supports the bull case. Price Target Raised After Strong Bookings Growth
- Positive Sentiment: Geopolitical headlines lifted defense-related names, including Axon, as investors favored companies exposed to public-safety and defense spending, providing near-term demand for the stock. Northrop Grumman, Axon and RTX lifted most as defense stocks gain on Iran war
- Neutral Sentiment: Axon presented at the Morgan Stanley TMT conference — management exposure at investor conferences increases visibility and can drive re-rating if they provide positive guidance, but the transcript contains no immediate market-moving surprise. Conference Presentation Transcript
- Neutral Sentiment: Recent data on short interest in the reporting snippets is anomalous/zeroed (NaN/0) and not informative — there’s no clear short squeeze signal from that data as published.
- Neutral Sentiment: Post-earnings coverage highlights a strong growth story (Axon 911, ARR growth) but also flags a very high forward earnings multiple, implying the stock needs near-perfect execution to justify the premium. This keeps sentiment mixed. Analysts: Axon can gain another 30%
- Negative Sentiment: An insider (Isaiah Fields) sold 2,000 shares at roughly $535, trimming his position by ~3.5%; insider selling can be perceived negatively even if modest in size. SEC Filing — Form 4
- Negative Sentiment: Coverage aggregated by TipRanks and others notes multiple insider sales across the company, which can weigh on sentiment if investors interpret the moves as insiders taking chips off the table. Top Axon Insiders Quietly Cash In
Analyst Ratings Changes
A number of brokerages have recently weighed in on AXON. Citigroup reissued a "buy" rating on shares of Axon Enterprise in a research note on Wednesday, February 25th. Craig Hallum reiterated a "buy" rating and set a $820.00 target price on shares of Axon Enterprise in a report on Wednesday, February 25th. TD Cowen reissued a "buy" rating on shares of Axon Enterprise in a report on Wednesday, November 5th. Royal Bank Of Canada reduced their price objective on Axon Enterprise from $860.00 to $735.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 25th. Finally, Wall Street Zen upgraded Axon Enterprise from a "sell" rating to a "hold" rating in a research report on Saturday. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $762.93.
View Our Latest Stock Analysis on AXON
Axon Enterprise Company Profile
(
Get Free Report)
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
